T3	Subject 69 78	a patient
T4	Treatment 92 96	IL-2
T5	Effect 31 65	cutaneous and hematologic toxicity
T7	Drug 92 96	IL-2
T6	Adverse_event 23 27	case
E1	Adverse_event:T6